MedTrace Logo

Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)

NCT04512573 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 232

Last updated 2024-12-04

No results posted yet for this study

Summary

This is a prospective, real-world observational study in which patients with RA who are initiating treatment with a JAK inhibitor medication will self-report disease activity and treatment satisfaction measures using their own web-enabled device such as a smartphone. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.

Conditions

  • Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)

Sponsors & Collaborators

  • CorEvitas

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-21
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512573 on ClinicalTrials.gov